Abeona Closes $155 Mln PRV Sale, Strengthens Cash Position Ahead Of ZEVASKYN Launch
3/7 05:15
(RTTNews) - Abeona Therapeutics Inc. (ABEO) has completed the sale of its Rare Pediatric Disease Priority Review Voucher or PRV for gross proceeds of $155 million, finalizing the transaction on June 27, 2025....